EFFEXOR (nda020151)- (EQ 12.5MG BASE,EQ 25MG BASE,EQ 50MG BASE,EQ 75MG BASE,EQ 100MG BASE,EQ 37.5MG BASE)

Generic Name	VENLAFAXINE HYDROCHLORIDE	Innovator	WYETH PHARMS INC
Dosage	EQ 12.5MG BASE,EQ 25MG BASE,EQ 50MG BASE,EQ 75MG BASE,EQ 100MG BASE,EQ 37.5MG BASE
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2017-Mar-20	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Effexor (venlafaxine hydrochloride) is indicated for the treatment of major depressive disorder.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
10	0	10

Other Developers

Total Other Developers	16

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 12.5MG BASE	**	**	-	-	-
EQ 25MG BASE	**	**	-	6	-
EQ 50MG BASE	**	**	-	-	6
EQ 75MG BASE	**	**	-	6	-
EQ 100MG BASE	**	**	-	-	6
EQ 37.5MG BASE	**	**	-	6	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	8

Manufacturing Details of EFFEXOR